MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
$38,310,000
EPS
$0.91
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenues
-2,000,000* -0
Cost of revenue
-1,987,000* -0
Gross profit
-13,000* -0
Research and development expenses
1,594,000 3,100,500* 1,153,000 1,034,000
General and administrative expenses
2,065,000 4,626,500* 1,274,000 1,455,000
Operating loss
-3,659,000 -7,714,000* -2,427,000 -2,489,000
Other income, net
8,250,000 -39,500* 408,000 257,000
Financial income (gain), net
44,849,000 -25,800,000* 61,470,000 15,366,000
Interest expenses
---0
Income (gain) before tax expenses
49,440,000 -33,553,500* 59,451,000 13,134,000
Tax expenses
11,130,000 -5,096,000* 11,062,000 -126,000
Net income (gain)
--28,457,500* 48,389,000 13,260,000
Non-controlling interests
-17,000* -6,000 -28,000
Net income (gain)
38,310,000 -28,474,500 48,395,000 13,288,000
Basic EPS
0.94 -0.699 1.16 0.32
Diluted EPS
0.91 -0.68 1.13 0.31
Basic Average Shares
40,773,866 40,709,204 41,756,301 41,743,486
Diluted Average Shares
41,970,186 41,872,003 42,774,504 42,609,425
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Financial income (gain),net$44,849,000 Other income, net$8,250,000 Income (gain) beforetax expenses$49,440,000 Operating loss-$3,659,000 Net income (gain)$38,310,000 Tax expenses$11,130,000 General andadministrative expenses$2,065,000 Research and developmentexpenses$1,594,000

ORAMED PHARMACEUTICALS INC. (ORMP)

ORAMED PHARMACEUTICALS INC. (ORMP)